Canadian Sec - Delayed Quote CAD

MyndTec Inc. (MYTC.CN)

Compare
0.0750 0.0000 (0.00%)
At close: December 17 at 11:03:09 AM EST
Loading Chart for MYTC.CN
DELL
  • Previous Close 0.0750
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.7500
  • Volume 0
  • Avg. Volume 898
  • Market Cap (intraday) 1.882M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0500
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

MyndTec Inc., a medical technology company, researches, develops, and distributes therapies for individuals with paralysis due to stroke or spinal cord injury in Canada and the United States. Its flagship product is MyndMove, a patented and proprietary functional electrical stimulator that applies advanced principles of neuroplasticity and functional electrical stimulation to assist patients with paralysis of the arm and hand to make lasting gains in the recovery of natural and voluntary movement. The company offers MyndMove or MyndSearch devices to clinics and research institutions, as well as sells device parts or treatment supplies. It serves hospitals through direct sales, as well as a network of distributors. The company was formerly known as Simple Systems Inc. and changed its name to MyndTec Inc. in April 2013. MyndTec Inc. was incorporated in 2008 and is headquartered in Mississauga, Canada.

www.myndtec.com

--

Full Time Employees

--

Fiscal Year Ends

Recent News: MYTC.CN

View More

Performance Overview: MYTC.CN

Trailing total returns as of 12/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MYTC.CN
85.00%
S&P/TSX Composite index
17.17%

1-Year Return

MYTC.CN
85.00%
S&P/TSX Composite index
19.62%

3-Year Return

MYTC.CN
92.11%
S&P/TSX Composite index
18.41%

5-Year Return

MYTC.CN
92.11%
S&P/TSX Composite index
43.82%

Compare To: MYTC.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MYTC.CN

View More

Valuation Measures

Annual
As of 12/18/2024
  • Market Cap

    1.88M

  • Enterprise Value

    2.26M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    15.26

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    18.88

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    -0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: MYTC.CN

View More

Company Insights: MYTC.CN

Research Reports: MYTC.CN

View More

People Also Watch